Pseudohypoparathyroidism: defective excretion of 3′, 5′-AMP in response to parathyroid hormone

LR Chase, GL Melson… - The Journal of clinical …, 1969 - Am Soc Clin Investig
LR Chase, GL Melson, GD Aurbach
The Journal of clinical investigation, 1969Am Soc Clin Investig
Urinary excretion of cyclic adenosine 3′, 5′-monophosphate (3′, 5′-AMP) was tested in
normal subjects and patients with pseudohypoparathyroidism, idiopathic
hypoparathyroidism, surgical hypoparathyroidism, and pseudopseudohypoparathyroidism
under basal conditions and after a 15 min infusion of purified parathyroid hormone. Basal
excretion of the nucleotide was less than normal in the patients with hypocalcemic disorders
and greater than normal in pseudopseudohypoparathyroidism. Parathyroid hormone …
Urinary excretion of cyclic adenosine 3′,5′-monophosphate (3′,5′-AMP) was tested in normal subjects and patients with pseudohypoparathyroidism, idiopathic hypoparathyroidism, surgical hypoparathyroidism, and pseudopseudohypoparathyroidism under basal conditions and after a 15 min infusion of purified parathyroid hormone. Basal excretion of the nucleotide was less than normal in the patients with hypocalcemic disorders and greater than normal in pseudopseudohypoparathyroidism. Parathyroid hormone caused a marked increase in excretion of 3′,5′-AMP in all subjects except those with pseudohypoparathyroidism; nine patients with this disorder did not respond to the hormone and four showed a markedly deficient response. Radioimmunoassay showed that parathyroid hormone circulated in increased amounts in plasma from patients with pseudohypoparathyroidism and became undetectable when serum calcium was increased above 12 mg/100 ml. Suppression of parathyroid hormone secretion by induction of hypercalcemia did not alter the deficient response to exogenous hormone. The results indicate that: (a) parathyroid hormone circulates in abnormally high concentrations in pseudohypoparathyroidism and secretion of the hormone responds normally to physiological control by calcium; (b) testing urinary excretion of 3′,5′-AMP in response to infusion of purified parathyroid hormone appears to be an accurate and sensitive index for establishing the diagnosis of pseudohypoparathyroidism; and (c) the metabolic defect of the disorder can be accounted for by a lack of or defective form of parathyroid hormone-sensitive adenyl cyclase in bone and kidney.
The Journal of Clinical Investigation